Northwestern University; Robert H. Lurie Comp Can Ctr

Chicago, Illinois 60611

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, B-Cell, Non-Small Cell Lung Cancer

Studies at this site

• A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) — Completed